Skip to main content
    E

    Envoy Medical Inc. (COCH)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.64
    +0.01 (+1.16%)

    Market Cap: $49.20M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    27%(3/11)
    Avg Surprise
    -20.45%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.07
    Range$-0.07 - $-0.06
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.06-11.2%
    60d ago$-0.07+4.7%
    30d ago$-0.07+4.7%
    7d ago$-0.07+4.7%
    Current$-0.07
    Revenue Consensus
    $85000
    Range$55000 - $100000
    3 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.00
    Range$-0.02 - $0.02
    3 analysts
    Revenue Consensus
    $8330
    Range$-25000 - $75000
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.00---
    Sep 26EST
    		-$-0.07---
    Jun 26
    Reported Aug 10
    		$-0.07$-0.09+22.22%Beat+78.1%
    Mar 26
    Reported May 11
    		$-0.08$-0.14+42.86%Beat+72.4%
    Dec 25
    Reported Mar 23
    		$-0.27$-0.29+7.79%Beat+41.9%
    Sep 25
    Reported Nov 10
    		$-0.35$-0.29-20.69%Miss+5.4%
    Jun 25
    Reported Jul 31
    		$-0.32$-0.29-10.34%Miss-18.5%
    Mar 25
    Reported May 1
    		$-0.29$-0.20-45.00%Miss+9.4%
    Dec 24
    Reported Mar 28
    		$-0.46$-0.31-48.39%Miss-17.9%
    Sep 24
    Reported Nov 14
    		$-0.37$-0.27-37.04%Miss-395.5%
    Jun 24
    Reported Aug 12
    		$-0.27$-0.25-8.00%Miss-254.3%
    Mar 24
    Reported May 15
    		$-0.32$-0.26-23.08%Miss-700.0%
    Dec 23
    Reported Mar 29
    		$-0.39$-0.19-105.26%Miss-931.7%
    Sep 23
    Reported Nov 17
    		$0.13N/AN/ABeat+13.8%
    Jun 23
    Reported Aug 30
    		$-0.08N/AN/ABeat-227.0%
    Mar 23
    Reported May 15
    		$-0.04N/AN/ABeat-117.4%
    Dec 22
    Reported Dec 31
    		$-0.04N/AN/ABeat+58.0%
    Sep 22
    Reported Nov 14
    		$0.11N/AN/ABeat+10.0%
    Jun 22
    Reported Aug 15
    		$0.06N/AN/ABeat+500.0%
    Mar 22
    Reported May 16
    		$0.23N/AN/ABeat+866.7%
    Dec 21
    Reported Mar 31
    		$-0.09N/AN/ABeat-
    Sep 21
    Reported Nov 12
    		$0.10N/AN/ABeat-
    Jun 21
    Reported Aug 17
    		$0.01N/AN/ABeat-
    Mar 21
    Reported May 17
    		$-0.03$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.84EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-10920.00%
    ROE0.00%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio1.73xQuick Ratio1.61x
    Trading Statistics
    Beta1.95Avg Volume70.05K
    52-Week High$0.9552-Week Low$0.36

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.65
    SMA 20$0.68
    SMA 50$0.71
    SMA 200$0.69
    EMA 10$0.66
    EMA 20$0.67
    EMA 50$0.69
    EMA 200$0.75

    MACD

    Line: -0.02Signal: -0.01Hist: -0.00

    ADX

    ADX: 34.9+DI: 4.9-DI: 22.8

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down100.0
    PSAR$0.69

    Bollinger Bands

    Upper Band$0.74
    Lower Band$0.62
    %B Position1744%(Upper)
    Band Width0.21

    RSI (14-Day)

    Neutral
    39.9

    Momentum Oscillators

    Stoch %K23.4
    Stoch %D18.2
    Williams %R-67.0
    ROC (10d)-2.4%
    Momentum-0.02
    CCI (20d)-126.6
    MFI (14d)41.3

    Volatility Measures

    ATR (14d)$0.03(5.0%)
    StdDev (20d)0.03
    Hist Vol37.3%(Moderate)

    Volume Flow

    VWAP$0.63
    OBV177.5M
    AD Line-37.4M
    CMF (20d)-0.164

    Volume Metrics

    Avg Vol (20d)64.6K
    Vol Ratio0.7x
    VWMA (20d)$0.67

    Pivot Points

    R3$0.70
    R2$0.68
    R1$0.66
    Pivot Point$0.64
    S1$0.62
    S2$0.60
    S3$0.58

    Advanced Oscillators

    TSI-17.17
    Ultimate Osc44.3
    KST-85.44

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$51,000$39,000$75,000$42,000$78,000$46,000$42,000$56,000$68,000$59,000$95,000$80,000
    Cost of Revenue$278,000$313,000$211,000$203,000$234,000$226,000$157,000$187,000$245,000$153,000$263,000$189,000
    Gross Profit$-227,000$-274,000$-136,000$-161,000$-156,000$-180,000$-115,000$-131,000$-177,000$-94,000$-168,000$-109,000
    Operating Expenses$5.34M$5.68M$6.25M$5.55M$4.91M$4.93M$4.43M$4.84M$4.67M$4.79M$6.55M$3.28M
    R&D$3.13M$3.64M$4.55M$2.70M$2.48M$2.75M$2.47M$2.76M$2.59M$2.36M$3.03M$1.85M
    SG&A$2.03M$1.88M$1.60M$2.44M$2.07M$1.82M$1.44M$1.69M$1.59M$2.10M$3.02M$1.03M
    Operating Income$-5,569,000$-5,959,000$-6,385,000$-5,708,000$-5,070,000$-5,107,000$-4,548,000$-4,972,000$-4,852,000$-4,884,000$-6,723,000$-3,385,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$201,000$471,000$624,000$495,000$384,000$264,000$132,000$36,000$0$0
    Income Before Tax$-5,982,000$-4,351,000$-6,586,000$-6,482,000$-5,690,000$-4,998,000$-4,618,000$-5,960,000$-3,947,000$-6,270,000$-4,986,000$1.56M
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-5,982,000$-4,351,000$-6,586,000$-6,482,000$-5,690,000$-4,998,000$-4,618,000$-5,960,000$-3,947,000$-6,270,000$-4,986,000$1.56M
    EBITDA$-5,672,000$-4,051,000$-6,276,000$-5,222,000$-4,112,000$-3,700,000$-3,564,000$-5,113,000$-3,336,000$-5,930,000$-4,336,000$1.59M
    EBIT$-5,982,000$-4,351,000$-6,586,000$-6,011,000$-5,066,000$-4,503,000$-4,234,000$-5,696,000$-3,815,000$-6,234,000$-4,986,000$1.56M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about COCH

    News

    Envoy Medical stock price target maintained at $2 by H.C. Wainwright

    H.C. Wainwright has reiterated a Buy rating and a $2.00 price target for Envoy Medical (NASDAQ:COCH) shares, following the company's regulatory advancements. This target implies a significant upside from the current...

    Investing.com Canada•10/13/26•Somewhat-Bullish

    Envoy Medical submits second FDA module for Acclaim implant By Investing.com

    Envoy Medical Inc. (NASDAQ:COCH) has submitted the second of four planned modules for its Modular Premarket Approval application for the Acclaim cochlear implant to the U.S. FDA. This module focuses on engineering...

    Investing.com Canada•10/12/26•Somewhat-Bullish

    Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant

    Envoy Medical Inc. has submitted the second module of its Modular Premarket Approval (PMA) application for the Acclaim® cochlear implant to the FDA. This module, primarily containing engineering information...

    Yahoo! Finance Canada•10/12/26•Bullish

    Lake Street initiates Envoy Medical stock at buy on cochlear device

    Lake Street has initiated coverage on Envoy Medical Inc. (NASDAQ:COCH) with a Buy rating and a $2.50 price target...

    Investing.com Canada•10/6/26•Somewhat-Bullish

    Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

    Envoy Medical Inc. has announced the grant of two new international patents in Canada and Hong Kong, expanding its global intellectual property portfolio to 97 patents. These patents cover technology related...

    TMX Newsfile•9/22/26•Neutral

    COCH Valuation and Fair Value

    P/E
    -0.8x
    P/B
    20.3x
    See GNG's fair value

    COCH Profitability: Margins, ROIC and FCF

    Gross margin
    -385.5%
    Operating margin
    -10920.0%
    Net margin
    0.0%
    ROE
    0.0%
    FCF margin
    -10488.4%

    COCH Competitors

    CompanyTicker
    Mereo BioPharma Group PLC ADRMREO
    Klotho Neurosciences, Inc.KLTO
    Tela Bio IncTELA
    Elicio Therapeutics Inc.ELTX
    iBio, Inc. Common StockIBIO
    Precision Optics Corporation, Inc. Common stockPOCI
    Myomo IncMYO
    ETHZilla CorporationETHZ

    Sector: Healthcare

    COCH Bull Case vs Bear Case

    Bear case

    • COCH beat EPS estimates in 37.5% of its last 8 reported quarters.
    • COCH's quarterly revenue changed -34.6% year over year.

    COCH Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -13.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.07
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    Frequently Asked Questions About COCH

    Does COCH pay dividends?

    Envoy Medical Inc. (COCH) does not currently pay a regular dividend.

    What is COCH's market cap?

    Envoy Medical Inc. (COCH) has a market capitalization of $49.20M with a current stock price of $0.64.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In